Press "Enter" to skip to content

Russia’s COVID-19 vaccine: Muscovites asked to take part in the trial

Muscovites are being encouraged to get involved in a brand new testing period of Russia’s coronavirus vaccine.

The”post-registration clinical” trial must last six months and demand around 40,000 individuals, Moscow’s mayor said in a statement.

The Russian Direct Investment Fund, which bankrolled the”Sputnik V” vaccine, stated it would alleviate similar offenses in five different nations, but did not name them.

Russia became the first nation on earth to provide a government go-ahead to get a COVID-19 vaccine on August 11.

But global medical specialists expressed unease, calling Russia’s fast-tracked acceptance and failure to discuss any information supporting claims of this vaccine’s efficiency a significant breach of scientific protocol.

At the moment, Russian officials stated mass vaccination could start as early as October. However, Moscow’s call for volunteers to get involved in trials would seem to cast doubt over this program.

Researchers in the World Health Organization said last week that though they’d started discussions with Russia regarding its vaccine, they hadn’t yet obtained any comprehensive data relating to it.

Talking to Euronews, the former associate commissioner of the US Food and Drug Administration (FDA), Peter Pitts, increased concerns regarding Russia’s vaccine statement.

“There is no data, there is no transparency, there is no FDA [Food and Drug Administration] at Russia [and] they have got a history of approving vaccines and drugs with very little if any testing,” he explained.

Experts cautioned that using an untested vaccine that hasn’t yet proven to be effective or safe may ultimately undermine the answer to the pandemic and trigger more distrust among individuals about whether or not to be vaccinated.

There’s not any certainty as to if a successful vaccine against coronavirus is going to be accepted.

At this time, 167 candidate vaccines are being analyzed, 32 of which undergoing human trials, such as eight that have proceeded to stage three, together with large-scale testing.